12-50809535-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_005171.5(ATF1):​c.274G>A​(p.Val92Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

ATF1
NM_005171.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.00
Variant links:
Genes affected
ATF1 (HGNC:783): (activating transcription factor 1) This gene encodes an activating transcription factor, which belongs to the ATF subfamily and bZIP (basic-region leucine zipper) family. It influences cellular physiologic processes by regulating the expression of downstream target genes, which are related to growth, survival, and other cellular activities. This protein is phosphorylated at serine 63 in its kinase-inducible domain by serine/threonine kinases, cAMP-dependent protein kinase A, calmodulin-dependent protein kinase I/II, mitogen- and stress-activated protein kinase and cyclin-dependent kinase 3 (cdk-3). Its phosphorylation enhances its transactivation and transcriptional activities, and enhances cell transformation. Fusion of this gene and FUS on chromosome 16 or EWSR1 on chromosome 22 induced by translocation generates chimeric proteins in angiomatoid fibrous histiocytoma and clear cell sarcoma. This gene has a pseudogene on chromosome 6. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06381416).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATF1NM_005171.5 linkc.274G>A p.Val92Ile missense_variant 4/7 ENST00000262053.8 NP_005162.1 P18846-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATF1ENST00000262053.8 linkc.274G>A p.Val92Ile missense_variant 4/71 NM_005171.5 ENSP00000262053.3 P18846-1
ATF1ENST00000552487.1 linkc.274G>A p.Val92Ile missense_variant 4/65 ENSP00000448921.1 F8VYN3
ATF1ENST00000552510.5 linkc.274G>A p.Val92Ile missense_variant 4/55 ENSP00000448592.1 F8VS03
ATF1ENST00000551831.5 linkn.94-4475G>A intron_variant 2 ENSP00000448987.1 F8VYE5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
36
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2024The c.274G>A (p.V92I) alteration is located in exon 4 (coding exon 3) of the ATF1 gene. This alteration results from a G to A substitution at nucleotide position 274, causing the valine (V) at amino acid position 92 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
13
DANN
Benign
0.30
DEOGEN2
Benign
0.0067
T;T;T
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.32
T;T;T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.064
T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.72
.;N;.
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.040
N;N;N
REVEL
Benign
0.024
Sift
Benign
1.0
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0010
.;B;.
Vest4
0.058
MutPred
0.42
Gain of catalytic residue at S94 (P = 2e-04);Gain of catalytic residue at S94 (P = 2e-04);Gain of catalytic residue at S94 (P = 2e-04);
MVP
0.29
MPC
0.25
ClinPred
0.095
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.10
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-51203318; API